Erythromelalgia in Adult
Erythromelalgia may be primary or secondary, with primary erythromelalgia (PE) further separated by some into a primary inherited form and an idiopathic group. Others consider only the inherited form as PE. This primary inherited form is due to an autosomal dominant mutation in the SCN9A gene on chromosome 2q that encodes for Nav 1.7 (voltage-gated sodium channels present in small nociceptive neurons). By contrast, secondary erythromelalgia can be associated with a multitude of underlying conditions. These include myeloproliferative disorders with thrombocythemia, in addition to vascular, connective tissue, neurological, and musculoskeletal conditions. Some drug reactions have been reported to trigger erythromelalgia, as have poisonings and intoxications.
Poisoning from ingestion of the mushroom Paralepistopsis (formerly Clitocybe) acromelalga causes a self-limited form of erythromelalgia. Onset is within 2-3 days of ingestion, and symptoms usually resolve in 1-2 weeks but may persist for months.
Incidence estimates have ranged from 0.3 to 1.3/100 000 for all forms of erythromelalgia, and these are considered low due to underdiagnosis. Some studies suggest a female predominance of up to 2-3:1, and there does not appear to be a racial / ethnic predilection.
I73.81 – Erythromelalgia
37151006 – Erythromelalgia
Differential Diagnosis & Pitfalls
- – triggered by cold
- – more continuous, unilateral, and worsened by cold
- – X-linked alpha-galactosidase deficiency on laboratory testing
- – primarily sensation changes
- – intermittent dysesthesia may be a symptom
- – localized and not chronically intermittent
- – urticarial swelling, lacks burning sensation
- – purpuric presentation
- – palmoplantar eruption seen with chemotherapy
- – episodic with history of cold exposure
- – scaling erythema with pruritus
- – sudden urticarial plaques, pruritic to painful
- – erythema with pruritus and scaling noted
Drug Reaction Data